Invokana is the Top Advertised Drug in Medical Journals Through July 2014

by Client Services

Invokana continues to be the most advertised drug product in professional health journals through July 2014. More than $12 million has been spent to advertise this product, which treats Type 2 Diabetes, according to Kantar Media. Brintellix, an antidepressant, is followed by Xarelto and Fetzima.

Top 5 Print Ad Drugs (Dollars): July 2014

#1 Invokana – $12 MM (+84%)

#2 Brintellix Tablets– $7 MM (N/A)

#3 Xarelto - $5 MM (-51%)

#4 Fetzima - $5 MM (N/A)

#5 Belviq (Lorcaserin HCI) IV – $4 MM (N/A)

The percentage changes compare July 2014 to that same time period in 2013. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.